CHARACTERIZATION OF RECOMBINANT HUMAN APO-B-48-CONTAINING LIPOPROTEINS IN RAT HEPATOMA MCA-RH7777 CELLS TRANSFECTED WITH APO-B-48 CDNA OVEREXPRESSION OF APO-B-48 DECREASES SYNTHESIS OF ENDOGENOUS APO-B-100
Mm. Hussain et al., CHARACTERIZATION OF RECOMBINANT HUMAN APO-B-48-CONTAINING LIPOPROTEINS IN RAT HEPATOMA MCA-RH7777 CELLS TRANSFECTED WITH APO-B-48 CDNA OVEREXPRESSION OF APO-B-48 DECREASES SYNTHESIS OF ENDOGENOUS APO-B-100, Arteriosclerosis, thrombosis, and vascular biology, 15(4), 1995, pp. 485-494
We studied the effect of overexpression of apolipoprotein (ape) B-48 o
n the synthesis and secretion of endogenous apoB-100 in rat hepatoma M
cA-RH7777 cell lines stably transfected with human apoB-48 cDNA under
the control of the cytomegalovirus promoter. Three cell lines that sec
rete 40 to 60 ng human apoB . mg cell protein(-1) . h(-1) were used. T
he recombinant human apoB-48 exhibited physicochemical characteristics
(buoyant density, 1.06 to 1.21 g/mL; beta-electrophoretic mobility an
d diameters, 16 to 20 nm) indistinguishable from those of endogenous r
at apoB-48. Overexpression of the recombinant human apoB-48 resulted i
n a 50% decrease in the secretion of endogenous apoB-100 but did not a
ffect the secretion of apoE or apoA-I. Several possible mechanisms for
the decreased secretion of apoB-100 were evaluated. First, recruitmen
t of lipids into lipoproteins was shown to be unaffected since no majo
r changes in the physicochemical properties of apoB-100-containing lip
oproteins were observed. Second, the intracellular degradation of apoB
-100 was not altered as the intracellular retention half-time and secr
etion efficiency remained unaffected by apoB-48 overexpression. Third,
the posttranslational regulatory mechanisms for apoB-100 remained nor
mal, as demonstrated by a twofold increase in apoB-100 secretion after
supplementation with oleic acid. Unexpectedly, a 35% to 50% decrease
in the steady-state synthesis of endogenous apoB-100 was observed in a
poB-48-transfected cells compared with control cells. These data sugge
sted that decreased secretion of apoB-100 was secondary to decreased s
ynthesis. The decreased apoB-100 synthesis was not due to decreased st
eady-state levels of rat apoB-100 mRNA. These results suggest that ove
rexpression of recombinant human apoB-48 may interfere with posttransc
riptional events, possibly at the translation-translocation level, and
decrease translational yield of apoB-100. These posttranscriptional e
vents prior to the complete synthesis of the apoB-100 polypeptide can
be important in the control of apoB-100 secretion.